Effect of Intrapartum Antibiotic Exposure Time on Neonatal Sepsis: A Prospective Cohort Study
- PMID: 40768031
- DOI: 10.1007/s13312-025-00133-2
Effect of Intrapartum Antibiotic Exposure Time on Neonatal Sepsis: A Prospective Cohort Study
Abstract
Objective: To examine the association between the duration of intrapartum antibiotic exposure (IAE) and the risk of culture-negative early-onset neonatal sepsis (EONS) and any late-onset neonatal sepsis (LONS) in the first week.
Methods: Preterm neonates (≤ 34 weeks) were enrolled into: Group A (no IAE; n = 282), Group B (IAE < 24 h; n = 204) and Group C (IAE ≥ 24 h; n = 84). The risk factors for EONS and LONS were noted and all neonates were followed up for culture-negative EONS (primary outcome). Secondary outcomes included culture-positive EONS, culture-negative and culture-positive LONS, and multidrug-resistant sepsis. A univariable followed by multivariable analysis of risk factors to predict culture-negative EONS and LONS was performed. The cut-off (Youden's index) of IAE associated with various outcomes was determined.
Results: From group A through C, gestation and birth weight declined, and the proportion at risk of EONS increased. Culture-negative EONS incidence increased (9.57% vs. 12.74% vs. 36.90%, respectively, Ptrends < 0.001), but its proportion among all EONS did not. Culture-positive LONS incidence declined (Ptrends = 0.038). The proportion of culture-negative LONS among all LONS increased (Ptrends = 0.024). Threshold values of 13.5 h and 4.5 h were associated with culture-negative EONS and culture-positive LONS in the first week, respectively. However, on adjusted analysis, IAE duration had no association with culture-negative EONS or LONS in the first week.
Conclusions: Duration of IAE is not independently associated with increased incidence of culture-negative EONS or any LONS.
Keywords: Antibiotic prophylaxis; Early-onset sepsis; Late-onset sepsis; Neonate.
© 2025. The Author(s), under exclusive licence to Indian Academy of Pediatrics.
Conflict of interest statement
Declarations. Conflict of interest: None. Ethical Approval: The study was conducted according to the Guidelines of the Helsinki Declaration and the National Ethical Guidelines for Biomedical and Health Research Involving Human Participants. Institute Ethics Committee Ref No: INT/IEC/2017/000318 dated Dec 30, 2017. Data Sharing: De-identified data available on reasonable request from corresponding author.
References
-
- Prevention of Group B Streptococcal early-onset disease in newborns: ACOG committee opinion, number 797. In: Obstet Gynecol. 2020;135:e51-e72.
-
- Milton R, Gillespie D, Dyer C, et al. Neonatal sepsis and mortality in low-income and middle-income countries from a facility-based birth cohort: an international multisite prospective observational study. Lancet Glob Health. 2022;10: e661–e72. - DOI
-
- van Schalkwyk J, Van Eyk N, Infectious Diseases C. Antibiotic prophylaxis in obstetric procedures. J Obstet Gynaecol Can. 2010;32:878-84
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
